- Acute Myeloid Leukemia (AML) Panel By PCR (1)
- Acute Myeloid Leukemia (AML) Panel By PCR
The “Acute Myeloid Leukemia (AML) Panel By PCR” is a specialized test offered by Redcliffelabs to diagnose and assess Acute Myeloid Leukemia, a type of cancer that affects the bone marrow and blood. The test is conducted using a blood sample, and fasting is not required. The reports are typically available in 9 days.
Significance of the Package: The “Acute Myeloid Leukemia (AML) Panel By PCR” is a highly specialized test that uses Polymerase Chain Reaction (PCR) technology to detect genetic abnormalities associated with Acute Myeloid Leukemia. This test can identify specific gene mutations and changes in the DNA of leukemia cells, which helps in confirming the diagnosis and guiding treatment decisions. AML is a type of cancer that affects the bone marrow and blood, and early and accurate diagnosis is crucial for effective treatment.
The test can provide insights into the specific genetic mutations present in leukemia cells, allowing healthcare professionals to tailor treatment plans based on the individual’s genetic profile. It can also be used to monitor the response to treatment and detect any signs of recurrence.
It’s important to interpret the results of this test in consultation with a qualified oncologist or hematologist. They will be able to provide a comprehensive understanding of the genetic information and its implications for treatment options and prognosis.